The global cell and gene therapy manufacturing services market is anticipated to grow significantly at a CAGR of nearly 11.5% over the forecast period. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships and collaborations, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance, in 2021, Charles River Laboratories acquired a cell & gene therapy contract development and manufacturing organization (CDMO) Cognate BioServices. The acquisition was intended to increase its cell and gene therapy manufacturing capabilities.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-and-gene-therapy-manufacturing-services-market
In addition to this, in 2021, Thermo Fisher Scientific Inc. acquired Henogen S.A., Novasep's viral vector manufacturing business in Belgium, for approximately $859.7 million. This acquisition is expected to increase its presence in the cell & gene therapy manufacturing therapy market. Further, in 2019, Thermo Fisher Scientific Inc. acquired Brammer Bio, a company involved in viral vector manufacturing for gene and cell therapies, for $1.7 billion.
Apart from this, FUJIFILM Cellular Dynamics opened a $21 million cGMP production facility to support its internal cell therapeutics pipeline, as well as serve as a CDMO for iPS cell products in 2021. Further, Anemocyte announced itself as the first BMO (Biotech Manufacturing Organization) in the field of cell and gene therapies. In addition to building 2000 sq. meters of GMP and GMP-compliant facilities for the production of ATMP’s, its FLYn’ICE project is using drones equipped with cryogenic pods to achieve temperature-controlled transit of cell and gene therapies.
Global Cell and Gene Therapy Manufacturing Services Market – Segmentation
By Therapy
- Cell Therapy
- Gene Therapy
By Scale
- Pre-commercial/ R&D Scale Manufacturing
- Commercial Scale Manufacturing
By Indication
- Cancer
- CVD
- Orthopedic
- Infectious Diseases
- Others
By End-User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
A full report of Cell and Gene Therapy Manufacturing Services Market is available at: https://www.omrglobal.com/industry-reports/cell-and-gene-therapy-manufacturing-services-market
Cell and Gene Therapy Manufacturing Services Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- bluebird bio, Inc.
- Boehringer Ingelheim International GmbH
- Catalent, Inc.
- Cell and Gene Therapy Catapult
- Innovative Cellular Therapeutics Co., Ltd.
- Charles River Laboratories International, Inc.
- Hoffmann-La Roche Ltd.
- FUJIFILM Holdings Corp.
- Miltenyi Biotec B.V. & Co. KG
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/